GL1X · GenesisL1 explorer

Research workbench

The R78K and D117E active site variants of saccharomyces cerevisiae soluble inorganic pyrophosphatase: structural studies and mechanistic implications

Analyse The R78K and D117E active site variants of saccharomyces cerevisiae soluble… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8PRK
Type
protein
Length
564 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein (inorganic pyrophosphatase)
EC
3.6.1.1
UniProt
P00817
Ligands
MN, PO4
Pockets
6 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 19% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtein (inorganic pyrophosphatase) (EC 3.6.1.1)protein28219% helix, 31% strandP00817

Ligands and binding sites

  • MN · Manganese (II) ion · metal · 6 copies · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16170.660.7646empty
21870.580.8128MN, PO4
31990.560.8033MN, PO4
4530.480.8520empty
5580.450.8319empty

Interfaces

1 interface between chains.

  • A–B · 999 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 8PRK · The R78K and D117E active site variants of saccharomyces cerevisiae soluble inorganic… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00817 · AlphaFold monomer V2.0 prediction for inorganic pyrophosphatase (P00817) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.